# Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer

> **NCT00019474** · PHASE2 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 60 (actual)

## Conditions studied

- Extrahepatic Bile Duct Cancer
- Gastric Cancer
- Gastrointestinal Carcinoid Tumor
- Liver Cancer
- Pancreatic Cancer
- Small Intestine Cancer

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** recombinant interferon alfa
- **DRUG:** fluorouracil
- **DRUG:** hydroxyurea

## Key facts

- **NCT ID:** NCT00019474
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-03
- **Primary completion:** 2000-08
- **Final completion:** 2000-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00019474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00019474, "Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00019474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*